Video Shorts

Why Syphilis Still Matters, With Kathryn Miele, MD

Why the Removal of RSV Antibodies in Pediatric Immunization Schedule is Cause for Concern

A Primary Care Physician's Story About Why Pediatric Immunization Matters

FDA First: Control-IQ+ AID Cleared for Pregnancy in Type 1 Diabetes

The Silent Crisis: Why Antibiotic Choice Matters

New Breast Cancer Screening Guidelines: What PCPs Need to Know

Why Young Adults With Diabetes Are Missing Critical Health Screenings

Why Rising Diabetes in Youth Demands a New Care Model

Women With Diabetes Miss Core Preventive Services: New Research

The Hidden Risks of Treating IBS with Antidepressants

When a Low 10-Year ASCVD Risk Masks Long-Term Danger: Clinical Pearls for Risk Stratification

Why Cardiovascular Risk Calculators Should Be a Tool—Not the Rule—for Clinical Decision-Making

Lp(a) and Cardiovascular Risk: Why Cardiologists Want Universal Screening and Cascade Testing

Type 2 Diabetes Management: Which Patients are Most Likely to Benefit from Once-Weekly Basal Insulin?

New Data From VESALIUS-CV Trial Show Evolocumab Cuts MACE Risk in High-Risk Diabetes Patients Without Prior Atherosclerosis

Is Once-Weekly Insulin Coming for Persons With Type 1 Diabetes?

Are Current Cholesterol Guidelines Too Conservative?

Why Once-Weekly Insulin is a Game-Changer for Adults with Type 2 Diabetes

Why Teenagers With Plaque Psoriasis Prefer Icotrokinra

Why Every Prescriber Must Offer PrEP: The Responsibility of Prevention

The iPhone Analogy: Reframing Vaccines as Essential, Life-Navigating Technology

Clinician Strategies for Talking to Mothers About Vaccine Safety

Where Does Icotrokinra Fit in Psoriasis Care?

The State Vaccine Crisis: Navigating New School Requirements

The Hidden Danger of Skipping "Optional" Vaccines

The Remaining Challenges With Modern HIV Therapy

How Allergy Labels Impact Pregnancy Health Outcomes

Why an Allergy 'Action Plan' is Better Than Just a Label, With Chang Su, MD

Why Primary Care Physicians Should Prescribe PrEP

A New Integrase-Free HIV Option? What CROI 2026 Phase 3 Data Show